SFPIA
CLVS

Stevens First Principles Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-400
Closed -$28K – 234
2014
Q1 		$28K Buy
+400
New +$29.4K 0.02% 151

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Stevens First Principles Investment Advisors's CLVS Position: Q2 2014 in Review

Stevens First Principles Investment Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q2 2014, closing a stake of 400 shares — an estimated $28K sold.

Stevens First Principles Investment Advisors first reported a position in CLVS in Q1 2014 and held it in 1 quarter. The position peaked at $28K in Q1 2014. 140 funds tracked by Wall St. Rank hold CLVS as of Q2 2014.

  • Stevens First Principles Investment Advisors reported no remaining Clovis Oncology, Inc. position as of Q2 2014 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 400 Clovis Oncology, Inc. shares in Q2 2014, an estimated $28K.
  • Stevens First Principles Investment Advisors first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 1 quarter.
  • Stevens First Principles Investment Advisors's Clovis Oncology, Inc. position peaked at $28K in Q1 2014.
  • 140 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2014.

Based on Stevens First Principles Investment Advisors's 13F filing for Q2 2014, filed 7 Aug 2014.